Key result
Injection of synthetic IK1 via dynamic clamp decreased the variability of action potential parameters and accentuated the shorter action potential phenotype in RA-treated hiPSC-CMs.
Answers are grounded in this paper and cite their sources.
Dynamic clamp-based IK1 injection improves action potential measurements in hiPSC-CMs, reducing variability and better distinguishing atrial-like from ventricular-like phenotypes.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for studying inherited cardiac arrhythmias and developing drug therapies to treat such arrhythmias. Unfortunately, until now, action potential (AP) measurements in hiPSC-CMs have been hampered by the virtual absence of the inward rectifier potassium current (IK1) in hiPSC-CMs, resulting in spontaneous activity and altered function of various depolarising and repolarising membrane currents. We assessed whether AP measurements in “ventricular-like” and “atrial-like” hiPSC-CMs could be improved through a simple, highly reproducible dynamic clamp approach to provide these cells with a substantial IK1 (computed in real time according to the actual membrane potential and injected through the patch-clamp pipette). APs were measured at 1 Hz using perforated patch-clamp methodology, both in control cells and in cells treated with all-trans retinoic acid (RA) during the differentiation process to increase the number of cells with atrial-like APs. RA-treated hiPSC-CMs displayed shorter APs than control hiPSC-CMs and this phenotype became more prominent upon addition of synthetic IK1 through dynamic clamp. Furthermore, the variability of several AP parameters decreased upon IK1 injection. Computer simulations with models of ventricular-like and atrial-like hiPSC-CMs demonstrated the importance of selecting an appropriate synthetic IK1. In conclusion, the dynamic clamp-based approach of IK1 injection has broad applicability for detailed AP measurements in hiPSC-CMs.
No takes yet. Share an insight, caveat, or question.
Verkerk et al. (2017) studied this question. Synthetic IK1 injection via dynamic clamp vs. Control cells (no IK1 injection) was evaluated on Action potential characteristics and variability. Injection of synthetic IK1 via dynamic clamp decreased the variability of action potential parameters and accentuated the shorter action potential phenotype in RA-treated hiPSC-CMs.
Synapse has enriched 10 related papers. Consider them for comparative context: